• Lynch Syndrome Multi Gene Panel (MLH1, MSH2, MSH6, PMS2 and EPCAM), Genomic Unity®
  • Lipase, Serum
  • Congestive cardiomyopathy
  • Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis
  • LiquidHALLMARK Multi Cancer Panel
  • Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
  • Endometriosis
  • Transferrin and Transferrin Saturation
  • DNA Cell Cycle Analysis by Flow Cytometry
  • OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Medical Test

Clinical Utility
Access to Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis is restricted.
Loading...